Orp8 deficiency in bone marrow-derived cells reduces atherosclerotic lesion progression in LDL receptor knockout mice

PLoS One. 2014 Oct 27;9(10):e109024. doi: 10.1371/journal.pone.0109024. eCollection 2014.

Abstract

Introduction: Oxysterol binding protein Related Proteins (ORPs) mediate intracellular lipid transport and homeostatic regulation. ORP8 downregulates ABCA1 expression in macrophages and cellular cholesterol efflux to apolipoprotein A-I. In line, ORP8 knockout mice display increased amounts of HDL cholesterol in blood. However, the role of macrophage ORP8 in atherosclerotic lesion development is unknown.

Methods and results: LDL receptor knockout (KO) mice were transplanted with bone marrow (BM) from ORP8 KO mice and C57Bl/6 wild type mice. Subsequently, the animals were challenged with a high fat/high cholesterol Western-type diet to induce atherosclerosis. After 9 weeks of Western-Type diet feeding, serum levels of VLDL cholesterol were increased by 50% in ORP8 KO BM recipients compared to the wild-type recipients. However, no differences were observed in HDL cholesterol. Despite the increase in VLDL cholesterol, lesions in mice transplanted with ORP8 KO bone marrow were 20% smaller compared to WT transplanted controls. In addition, ORP8 KO transplanted mice displayed a modest increase in the percentage of macrophages in the lesion as compared to the wild-type transplanted group. ORP8 deficient macrophages displayed decreased production of pro-inflammatory factors IL-6 and TNFα, decreased expression of differentiation markers and showed a reduced capacity to form foam cells in the peritoneal cavity.

Conclusions: Deletion of ORP8 in bone marrow-derived cells, including macrophages, reduces lesion progression after 9 weeks of WTD challenge, despite increased amounts of circulating pro-atherogenic VLDL. Reduced macrophage foam cell formation and lower macrophage inflammatory potential are plausible mechanisms contributing to the observed reduction in atherosclerosis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • ATP Binding Cassette Transporter 1 / genetics
  • ATP Binding Cassette Transporter 1 / metabolism
  • Animals
  • Antigens, CD / metabolism
  • Antigens, Differentiation, Myelomonocytic / metabolism
  • Atherosclerosis / genetics*
  • Atherosclerosis / pathology*
  • Atherosclerosis / therapy
  • Biomarkers
  • Bone Marrow Cells / metabolism*
  • Cholesterol / blood
  • Cholesterol / metabolism
  • Cytokines / metabolism
  • Disease Models, Animal
  • Female
  • Foam Cells / pathology
  • Gene Expression
  • Inflammation Mediators / metabolism
  • Leukocyte Count
  • Macrophages / metabolism
  • Male
  • Mice
  • Mice, Knockout
  • Mustard Gas
  • Plaque, Atherosclerotic / genetics
  • Plaque, Atherosclerotic / metabolism
  • Plaque, Atherosclerotic / pathology
  • Receptors, LDL / deficiency*
  • Receptors, LDL / genetics
  • Receptors, Steroid / deficiency*
  • Receptors, Steroid / genetics
  • Time Factors
  • Triglycerides / blood

Substances

  • ATP Binding Cassette Transporter 1
  • Antigens, CD
  • Antigens, Differentiation, Myelomonocytic
  • Biomarkers
  • CD68 antigen, human
  • Cytokines
  • Inflammation Mediators
  • Receptors, LDL
  • Receptors, Steroid
  • Triglycerides
  • oxysterol binding protein
  • Cholesterol
  • Mustard Gas

Grants and funding

This work was supported by The Netherlands Heart Foundation (Grant 2009B075 (EvK)), www.hartstichting.nl; The Netherlands Organization for Scientific Research (VICI Grant 91813603 (MVE)), www.nwo.nl/; the Sigrid Juselius Foundation, the Finnish Foundation for Cardiovascular Research, the Magnus Ehrnrooth Foundation, and the Academy of Finland (grant 121457 to VMO), www.sigridjuselius.fi/foundation, www.sydantutkimussaatio.fi, pro.tsv.fi/magnusehrnrooth, www.aka.fi. MVE is an Established Investigator of the Netherlands Heart Foundation (Grant 2007T056), www.hartstichting.nl. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.